{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:39:10Z","timestamp":1792132750991,"version":"4.4.0"},"reference-count":35,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sarepta Therapeutics"},{"name":"Muscular Dystrophy Association (MDA)"},{"name":"John Merck Fund"},{"name":"Revvity"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) is an X-linked progressive disorder and the most common type of muscular dystrophy in children. As newborn screening (NBS) for DMD undergoes evaluation for the Recommended Uniform Screening Panel and is already mandated in multiple states, refining NBS algorithms is of utmost importance. NBS for DMD involves measuring creatine kinase-MM (CK-MM) concentration\u2014a biomarker of muscle damage\u2014in dried blood spots. The current test is FDA-approved for samples obtained less than 72 h after birth. Separate reference ranges are needed for samples collected later than 72 h after birth. In this study, we investigated the relationship between age and CK-MM in presumed healthy newborns to inform NBS algorithm designs. In patients with DMD, CK-MM is persistently elevated in childhood and adolescence, while it may be transiently elevated for other reasons in healthy newborns. CK-MM decrease over time was demonstrated by a population sample of 20,306 presumed healthy newborns tested between 0 and 60 days of life and repeat testing of 53 newborns on two separate days. In the population sample, CK-MM concentration was highest in the second 12 h period of life (median = 318 ng\/mL) when only 57.6% of newborns tested below 360 ng\/mL, the lowest previously published cutoff. By 72 h of age, median CK-MM concentration was 97 ng\/mL, and 96.0% of infants had concentrations below 360 ng\/mL. Between 72 h and 60 days, median CK-MM concentration ranged from 32 to 37 ng\/mL. Establishing age-related cutoffs is crucial for optimizing the sensitivity and specificity of NBS for DMD.<\/jats:p>","DOI":"10.3390\/ijns10020041","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T11:47:17Z","timestamp":1718797637000},"page":"41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Age-Related Blood Levels of Creatine Kinase-MM in Newborns and Patients with Duchenne Muscular Dystrophy: Considerations for the Development of Newborn Screening Algorithms"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8640-8992","authenticated-orcid":false,"given":"Sarah Nelson","family":"Potter","sequence":"first","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 22709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-8371","authenticated-orcid":false,"given":"Brooke","family":"Migliore","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 22709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-9283","authenticated-orcid":false,"given":"Javan","family":"Carter","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 22709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica R.","family":"Copeland","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 22709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-9377","authenticated-orcid":false,"given":"Edward C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, NC 27710, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3053-7453","authenticated-orcid":false,"given":"Holly L.","family":"Peay","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 22709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-6599","authenticated-orcid":false,"given":"Katerina S.","family":"Kucera","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, Durham, NC 22709, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"960363","DOI":"10.1155\/2012\/960363","article-title":"Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery","volume":"2012","author":"Baird","year":"2012","journal-title":"J. Nutr. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/ptj\/85.12.1372","article-title":"The muscular dystrophies: From genes to therapies","volume":"85","author":"Lovering","year":"2005","journal-title":"Phys. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed diagnosis in duchenne muscular dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)","volume":"155","author":"Ciafaloni","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.27532","article-title":"Time to diagnosis of Duchenne muscular dystrophy remains unchanged: Findings from the Muscular Dystrophy Surveillance, Tracking, and Research Network, 2000\u20132015","volume":"66","author":"Thomas","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41431-022-01138-2","article-title":"Incidence of Duchenne muscular dystrophy in the modern era; an Australian study","volume":"30","author":"Kariyawasam","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","article-title":"Female dystrophinopathy: Review of current literature","volume":"28","author":"Ishizaki","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10072-022-06128-2","article-title":"Duchenne muscular dystrophy newborn screening: The first 50,000 newborns screened in Taiwan","volume":"43","author":"Chien","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dantonio, P., Tavakoli, N.P., Migliore, B., McCown, E., Lim, T., Park, S., Caggana, M., Kucera, K.S., Phan, H., and Street, N. (2023). Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays. Int. J. Neonatal Screen., 9.","DOI":"10.3390\/ijns9010013"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hartnett, M.J., Lloyd-Puryear, M.A., Tavakoli, N.P., Wynn, J., Koval-Burt, C.L., Gruber, D., Trotter, T., Caggana, M., Chung, W.K., and Armstrong, N. (2022). Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8040050"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e11071","DOI":"10.1016\/j.heliyon.2022.e11071","article-title":"A pilot study of newborn screening for Duchenne muscular dystrophy in Guangzhou","volume":"8","author":"Jia","year":"2022","journal-title":"Heliyon"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2022.11.024","article-title":"Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China","volume":"539","author":"Jia","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12519-017-0036-3","article-title":"Newborn screening for Duchenne muscular dystrophy in China: Follow-up diagnosis and subsequent treatment","volume":"13","author":"Ke","year":"2017","journal-title":"World J. Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101009","DOI":"10.1016\/j.gim.2023.101009","article-title":"Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina","volume":"26","author":"Kucera","year":"2024","journal-title":"Genet. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Maloney, B., Park, S., Sowizral, M., Brackett, I., Moslehi, R., Chung, W.K., Gruber, D., Brower, A., Lloyd-Puryear, M., and Caggana, M. (2023). Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy. Clin. Biochem., 118.","DOI":"10.1016\/j.clinbiochem.2023.110614"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Migliore, B.A., Zhou, L., Duparc, M., Robles, V.R., Rehder, C.W., Peay, H.L., and Kucera, K.S. (2022). Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy. Int. J. Neonatal Screen., 8.","DOI":"10.3390\/ijns8010012"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Parad, R.B., Sheldon, Y., and Bhattacharjee, A. (2021). Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7040077"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.27533","article-title":"Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy","volume":"65","author":"Park","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/acn3.51829","article-title":"Newborn screening for Duchenne muscular dystrophy: A two-year pilot study","volume":"10","author":"Tavakoli","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Timonen, A., Lloyd-Puryear, M., Hougaard, D.M., Meri\u00f6, L., M\u00e4kinen, P., Laitala, V., P\u00f6l\u00f6nen, T., Skogstrand, K., Kennedy, A., and Airenne, S. (2019). Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP(\u00ae) Neonatal Creatine Kinase-MM Kit in a US and Danish Population. Int. J. Neonatal Screen., 5.","DOI":"10.3390\/ijns5030027"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-2007-1025460","article-title":"[Creatine-kinase MM in the perinatal period]","volume":"203","author":"Amato","year":"1991","journal-title":"Klin. Padiatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1373\/clinchem.2016.268425","article-title":"Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy","volume":"63","author":"Moat","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_25","unstructured":"Health Resources & Services Administration (2024, March 11). Newborn Screening Process, Available online: https:\/\/newbornscreening.hrsa.gov\/newborn-screening-process."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JND-221535","article-title":"Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy","volume":"10","author":"Farrar","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2008.08.033","article-title":"Relationship of ethnic origin, gender, and age to blood creatine kinase levels","volume":"122","author":"Neal","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajmg.c.32000","article-title":"Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy","volume":"190","author":"Gruber","year":"2022","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.pedneo.2022.11.001","article-title":"The modern face of newborn screening","volume":"64","author":"Chien","year":"2023","journal-title":"Pediatr. Neonatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jmoldx.2019.11.002","article-title":"Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System","volume":"22","author":"Lee","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"ref_31","first-page":"e975","article-title":"Longitudinal Assessment of Creatine Kinase, Creatine\/Creatinine(ratio), and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy","volume":"100","author":"Koeks","year":"2023","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0022-510X(91)90068-I","article-title":"Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy","volume":"102","author":"Zatz","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"De Palma, F.D.E., Nunziato, M., D\u2019Argenio, V., Savarese, M., Esposito, G., and Salvatore, F. (2021). Comprehensive Molecular Analysis of DMD Gene Increases the Diagnostic Value of Dystrophinopathies: A Pilot Study in a Southern Italy Cohort of Patients. Diagnostics, 11.","DOI":"10.3390\/diagnostics11101910"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41431-020-0643-7","article-title":"EMQN best practice guidelines for genetic testing in dystrophinopathies","volume":"28","author":"Fratter","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ejhg.2013.82","article-title":"Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD\/BMD: A multi-population diagnostic study","volume":"22","author":"Wei","year":"2014","journal-title":"Eur. J. Hum. Genet."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/2\/41\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:01:15Z","timestamp":1760108475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/2\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijns10020041"],"URL":"https:\/\/doi.org\/10.3390\/ijns10020041","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]}}}